Status:

COMPLETED

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Parkinson Disease

Eligibility:

All Genders

20+ years

Phase:

PHASE3

Brief Summary

To evaluate the efficacy and safety of long-term treatment with pramipexole tablets (BI Sifrol®) in Parkinson's disease (phase III study).

Detailed Description

The efficacy and safety of long-term treatment with pramipexole (BI Sifrol®) were evaluated in Parkinson disease patients in an open-label non-controlled design. The treatment was initiated at 0.125 m...

Eligibility Criteria

Inclusion

  • Patients with a diagnosis of Parkinson's disease (including juvenile parkinsonism)
  • (1) Patients meeting all of the following inclusion criteria
  • Patients of at least 20 years of age
  • In- or outpatients of either sex.
  • Patients in any stage on the modified Hoehn and Yahr severity scale

Exclusion

  • Patients with psychiatric symptoms such as confusion, hallucination, delusion, excitement, delirium, and abnormal behaviour.
  • Patients with subjective symptoms derived from orthostatic hypotension.
  • Patients with hypotension (systolic blood pressure \<100 mmHg)
  • Patients with concomitant illness such as severe cardiac, renal, and hepatic disease
  • Patients with a current or past history of epilepsy
  • Pregnant, possibly pregnant, or lactating women
  • Patients receiving any other investigational products or who have received any other investigational product within 6 months of the study.
  • Patients who judged incompetent to give consent
  • Others judged by the investigator or co-investigator to be ineligible as subjects.

Key Trial Info

Start Date :

December 1 1998

Trial Type :

INTERVENTIONAL

End Date :

February 1 2004

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT00274131

Start Date

December 1 1998

End Date

February 1 2004

Last Update

May 21 2012

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease | DecenTrialz